Literature DB >> 21908025

Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia.

Akira Tsujimura1, Tetsuya Takao, Yasushi Miyagawa, Hidenobu Okuda, Keisuke Yamamoto, Shinichiro Fukuhara, Jiro Nakayama, Tomohiro Ueda, Hiroshi Kiuchi, Toshiaki Hirai, Yuichi Tsujimoto, Hidenobu Miura, Nobuteru Kanno, Makoto Higashino, Yoshihiro Nakamura, Kenji Nishimura, Norio Nonomura.   

Abstract

OBJECTIVE: To evaluate the relation between bother and overactive bladder (OAB) symptoms in patients with benign prostatic hyperplasia (BPH) patients using questionnaires: the BPH Impact Index (BII) and the OAB symptom score (OABSS). Annoyance from BPH usually provides the basis for a patient's decision to seek medical treatment. However, a study investigating the bother caused by OAB symptoms in patients with BPH and OAB has not been fully conducted.
METHODS: The present study included 100 male patients who were diagnosed with BPH and OAB according to questionnaire criteria. All patients were instructed to take tamsulosin for 28 days. The relation between the BII and OABSS was assessed to determine the factors influencing OAB symptoms on the BII before and after treatment.
RESULTS: The BII correlated positively with the OABSS, and multivariate analysis showed that the subscore of urgency was the only independent factor influencing the BII. Even after treatment, lower urinary tract symptoms were diagnosed as OAB using the OABSS criteria in 45 (45.0%) of the 100 patients. In these patients, the BII still correlated positively with the OABSS. However, multivariate analysis showed that the subscore of urgency incontinence, not urgency, was the only independent factor influencing the BII, although the subscore of urgency incontinence was significantly decreased with tamsulosin treatment.
CONCLUSION: The degree of bother correlated with the degree of OAB symptoms in patients with BPH and OAB at baseline and after treatment with tamsulosin. The OAB symptom causing the bother was altered by treatment with tamsulosin in these patients. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21908025     DOI: 10.1016/j.urology.2011.05.032

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Lack of Patient-Clinician Concordance in Cancer Patients: Its Relation With Patient Variables.

Authors:  Kavita D Chandwani; Fengmin Zhao; Gary R Morrow; Teresa L Deshields; Lori M Minasian; Judith Manola; Michael J Fisch
Journal:  J Pain Symptom Manage       Date:  2017-02-06       Impact factor: 3.612

2.  Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms.

Authors:  Seong Jin Jeong; Yukio Homma; Seung-June Oh
Journal:  Qual Life Res       Date:  2013-05-29       Impact factor: 4.147

Review 3.  Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.

Authors:  Anne Pavy-Le Traon; Nikki Cotterill; Gerard Amarenco; Susanne Duerr; Horacio Kaufmann; Heinz Lahrmann; François Tison; Gregor K Wenning; Christopher G Goetz; Werner Poewe; Cristina Sampaio; Anette Schrag; Olivier Rascol; Pablo Martinez-Martin; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2018-10-25

4.  Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia.

Authors:  Won Sok Hur; Joon Chul Kim; Hyo Sin Kim; Jun Sung Koh; Sang Hoon Kim; Hyun Woo Kim; Su Yeon Cho; Kang Jun Cho
Journal:  Investig Clin Urol       Date:  2016-10-24

5.  Validation of the Arabic linguistic version of the Overactive Bladder Symptoms Score questionnaire.

Authors:  M A Elbaset; Abdelwahab Hashem; Diaa-Eldin Taha; Mohamad H Zahran; Ahmed S El-Hefnawy
Journal:  Arab J Urol       Date:  2019-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.